Indivior PLC
LSE:INDV

Watchlist Manager
Indivior PLC Logo
Indivior PLC
LSE:INDV
Watchlist
Price: 790 GBX -0.82% Market Closed
Market Cap: 1B GBX
Have any thoughts about
Indivior PLC?
Write Note

Indivior PLC
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Indivior PLC
Research & Development Peer Comparison

Comparables:
GSK
AZN
VRNA
HIK
DPH

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Indivior PLC
LSE:INDV
Research & Development
-$102m
CAGR 3-Years
-32%
CAGR 5-Years
-12%
CAGR 10-Years
-1%
GlaxoSmithKline PLC
LSE:GSK
Research & Development
-ÂŁ6B
CAGR 3-Years
-10%
CAGR 5-Years
-8%
CAGR 10-Years
-6%
AstraZeneca PLC
LSE:AZN
Research & Development
-$11B
CAGR 3-Years
-31%
CAGR 5-Years
-14%
CAGR 10-Years
-9%
Verona Pharma PLC
NASDAQ:VRNA
Research & Development
-$40.8m
CAGR 3-Years
15%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Research & Development
-$146m
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
-14%
Dechra Pharmaceuticals PLC
LSE:DPH
Research & Development
-ÂŁ57.5m
CAGR 3-Years
-27%
CAGR 5-Years
-26%
CAGR 10-Years
-22%

See Also

What is Indivior PLC's Research & Development?
Research & Development
-102m USD

Based on the financial report for Jun 30, 2024, Indivior PLC's Research & Development amounts to -102m USD.

What is Indivior PLC's Research & Development growth rate?
Research & Development CAGR 10Y
-1%

Over the last year, the Research & Development growth was 6%. The average annual Research & Development growth rates for Indivior PLC have been -32% over the past three years , -12% over the past five years , and -1% over the past ten years .

Back to Top